William Lewis's Net Worth
$45.4 Million
Who is William Lewis?
William Lewis has an estimated net worth of $45.4 Million. This is based on reported shares across multiple companies, which include uniQure N.V., INSMED Inc, Aegerion Pharmaceuticals, Inc., and NewAmsterdam Pharma Co N.V..
SEC CIK
William Lewis's CIK is 0001402051
Past Insider Trading and Trends
2020 was William Lewis's most active year for acquiring shares with 16 total transactions. William Lewis's most active month to acquire stocks was the month of December. 2020 was William Lewis's most active year for disposing of shares, totalling 37 transactions. William Lewis's most active month to dispose stocks was the month of October. 2019 saw William Lewis paying a total of $8,163,909.60 for 1,162,249 shares, this is the most they've acquired in one year. In 2019 William Lewis cashed out on 677,684 shares for a total of $10,400,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
uniQure N.V. (QURE) Snapshot price: $5.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INSMED Inc (INSM) Snapshot price: $71.04
Chair and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.64% | 20.51K |
$25.52 | -$566,492.96 | 384.13K |
May 13 - May 14
| |||
Form 4
| +10,000.00% | 50K |
$12.58 | $629,000.00 | 50.5K |
Feb 28
| |||
Form 4
| -2.65% | -9.89K |
$24.91 | -$688,419.17 | 363.65K |
Scheduled
|
Jan 8 - Jan 9
| ||
Form 4
| +9.02% | 30.89K |
$29.26 | -$204,195.07 | 373.54K |
Jan 4 - Jan 5
| |||
Form 4
| +0.21% | 500 |
$19.16 | -$1,094,449.43 | 234.42K |
Scheduled
|
Oct 27
| ||
Form 4
| -4.71% | -16.86K |
$18.58 | -$313,311.66 | 341.35K |
May 15 - May 17
| |||
Form 4
| +123.39% | 327.06K |
$12.44 | $2,910,014.56 | 592.13K |
May 11 - May 12
| |||
Form 4
| -2.57% | -6.99K |
$18.00 | -$125,892.00 | 265.07K |
Jan 10
| |||
Form 4
| +5.98% | 15.35K |
$19.80 | -$138,758.40 | 272.06K |
Jan 5
| |||
Form 4
|
—
|
0
|
$16.11 | -$5,084,354.46 |
0
|
Scheduled
|
Aug 8
| ||
Form 4
|
—
|
0
|
$19.58 | -$660,839.76 | 256.72K |
Scheduled
|
Jul 7
| ||
Form 4
| -3.54% | -9.39K |
$19.52 | -$183,352.58 | 255.83K |
May 16 - May 17
| |||
Form 4
| +21.87% | 47.6K |
—
|
—
| 265.22K |
May 11
| |||
Form 4
|
—
|
0
|
$19.36 | -$734,777.21 | 217.62K |
Scheduled
|
Mar 23
| ||
Form 4
| -1.30% | -2.87K |
$25.11 | -$72,141.03 | 217.62K |
Jan 11
| |||
Form 4
| +16.20% | 30.74K |
—
|
—
| 220.5K |
Jan 6
| |||
Form 4
| -6.16% | -12.46K |
$26.92 | -$335,510.86 | 189.76K |
Jan 5 - Jan 6
| |||
Form 4
|
—
|
0
|
$20.92 | -$1,363,527.10 | 202.22K |
Scheduled
|
Dec 23 - Dec 27
| ||
Form 4
|
—
|
0
|
$15.38 | -$2,315,265.12 | 202.22K |
Scheduled
|
Sep 30
| ||
Form 4
| -3.12% | -6.48K |
$26.23 | -$169,996.63 | 201.47K |
May 15
| |||
Form 4
| +15.78% | 28.34K |
—
|
—
| 207.95K |
May 12
| |||
Form 4
|
—
|
0
|
$19.79 | -$1,639,280.61 | 179.61K |
Scheduled
|
Mar 16
| ||
Form 4
| +13.99% | 22.04K |
—
|
—
| 179.61K |
Jan 7
| |||
Form 4
| -4.38% | -7.22K |
$33.34 | -$240,672.41 | 157.57K |
Jan 3 - Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30 - Jan 4
| |||
Form 4
|
—
|
0
|
$19.99 | -$1,658,665.49 | 164.79K |
Scheduled
|
Dec 22
| ||
Form 4
| +21.04% | 28.64K |
$19.39 | -$5,787,390.29 | 164.79K |
May 15 - Nov 6
| |||
Form 4
| +63.83% | 52.63K |
—
|
—
| 135.09K |
Jan 3
| |||
Form 4/A
| +136.80% | 277.68K |
$3.40 | $944,125.60 | 480.67K |
Jun 25
| |||
Form 4
| -60.26% | -122.32K |
$26.00 | -$3,180,216.00 | 80.67K |
Jun 25
| |||
Form 4
| +34.21% | 51.74K |
—
|
—
| 202.99K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +11.58% | 15.7K |
$15.90 | $249,600.17 | 151.25K |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
| +39.78% | 38.58K |
—
|
—
| 135.55K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +106.45% | 50K |
$13.34 | $667,000.00 | 96.97K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31 - Jan 10
| |||
Form 4
| +12.54% | 5.23K |
$14.28 | $74,727.24 | 46.97K |
Scheduled
|
Nov 1
| ||
Form 4
| +22.21% | 7.58K |
$9.83 | $74,547.40 | 41.74K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +40.33% | 9.82K |
$7.58 | $74,405.28 | 34.15K |
Scheduled
|
Apr 1
| ||
Form 4
| +79.38% | 10.77K |
$6.90 | $74,313.00 | 24.34K |
Scheduled
|
Jan 9
| ||
Form 4
|
∞
| 13.57K |
$7.36 | $99,860.48 | 13.57K |
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
President, PFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NewAmsterdam Pharma Co N.V. (NAMS) Snapshot price: $16.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||